
Decoding the Mysteries of Hypogonadotropic Hypogonadism 10 without Anosmia
An intact sense of smell sets this form apart from Kallmann syndrome; hormone labs, MRI and testing of genes such as FGFR1 and SOX10 confirm HH10.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

An intact sense of smell sets this form apart from Kallmann syndrome; hormone labs, MRI and testing of genes such as FGFR1 and SOX10 confirm HH10.

Testing for a homozygous CST6 variant can confirm Hypotrichosis 3 and identify relatives who carry it without sparse hair, dry skin or impaired sweating.

Benign stomach polyps tied to BMPR1A, PTEN and SMAD4 can bleed and carry gastric cancer risk; endoscopy, biopsy and gene testing shape surveillance and treatment.

Prions passed on through funeral practices among the Fore people caused Kuru; carriers of the PRNP variant G127V are less likely to develop the disease.

Birth weight above the 90th percentile defines LGA. Causes include maternal diabetes, obesity and genetic predisposition; testing can spot chromosomal changes.

Fetal LCHAD deficiency has been linked to acute fatty liver in the mother. Carrier screening, prenatal testing and newborn diagnosis are each explained.

Muscle weakness, poor coordination, breathing problems and developmental delay follow complex I failure; MRI, lactic acid and NDUFS2 testing are used.

When leptin is lacking or the body resists it, appetite and energy expenditure fall out of balance; lipodystrophy links are outlined too.